The tyrosine kinase activity of the insulin receptor was investigated in skeletal muscle biopsies from insulin-resistant males with obesity or with Type 2 (non-insulin-dependent) diabetic males who were lean or overweight. The kinase activity of the receptor from all three groups of insulin-resistant subjects was 40% less when compared to the activity of lean control subjects. This alteration was present in the absence of changes in the level of the insulin receptor on its insulin binding characteristics. We conclude that the tyrosine kinase activity of the skeletal muscle insulin receptor is defective in obesity and Type 2 diabetes, and that this alteration contributes to the insulin-resistant characteristics of both disorders.
Subjects and methods

Subjects
All subjects were males between 60-70 years of age, who participated in a health screening study in Uppsala, a middle-sized town in Sweden [2] . The subjects were drug-free and healthy except for obesity and Type 2 diabetes in affected individuals. The diabetic patients were divided into two groups, non-obese patients and patients who were overweight. Diabetes was diagnosed during the health screening procedure: in these patients, fasting blood glucose was moderately elevated but urinary glucose and ketones were absent. After an overnight fast, plasma glucose, plasma insulin, intravenous glucose tolerance, and body mass index were determined as described [2] in 7 non-obese healthy subjects, 20 moderately obese non-diabetic subjects, 8 moderately obese Type 2 diabetic patients, and 8 non-obese Type 2 diabetic patients. On a separate day after an overnight fast, two or three muscle biopsies (200-300 mg total wet weight) were taken from the left vastus lateralis muscle. The biopsies were immediately frozen in liquid N2 and maintained in N2 until used for the receptor studies. For ethical reasons it was not possible ~o obtain larger quantities of muscle from each donor. All subjects consumed a similar diet (10.5 MJ/24 h) that consisted of 35% fat, 48% carbohydrate, 15% protein and 2% alcohol according to dietary history [2] .
Insulin binding to muscle insulin receptors
The frozen muscle biopsies were extracted at 4 ~ with 5 ml of Tris buffer, pH 7.4 that contained 1% Triton X-100. 5 mmol/1 (ortho) vanadate, 2 mmol/1 p-nitropbenyl phosphate, I retool/1 phenylmethylsulfonyl fluoride (PMSF), 100 mmol/l NaF, 5 mmol/1 EDTA, and 1 mg/ml bacitracin. Following a 30 rain extraction period, 15 ml of this buffer minus Triton X-100 was added and the insoluble material removed by centrifugation (30,000 g for 30 rain). The supernate was subjected to membrane filtration (Metricle filter GA-6, 0.45 p.m) and the filtrate was cycled three times over a I ml wheat germ agglutin affinity column [3] . The column was washed overnight with a 50 mmol/1 Tris buffer, pH 7.4, that contained 0.5 mol/1 NaC1, t mmol/1 PMSF, and 0.1% Triton X-100. The column was subjected to centrifugation (800 g for 30 s) to remove the remaining wash buffer. Elution buffer (900 ~tl) that contained 50 mmol/1 Tris, pH 7.4, 0.1% Triton X-t00, 1 mol/1 NaC1, and 0.3 mol/1 n-acetylglucosamine was mixed with the "dried" column material. After t h the eluate that contained the insulin receptor was collected by repeating the centrifugation step. The recovery with this procedure was 35% _+ 0.5% (mean + SEM) in 6 separate experiments. Insulin binding activity was measured in a 50 Ixl assay using a tracer 125I-insulin (A-14) of 50 mol/1 and various concentrations of native insulin in a 50-mmol/1 Tris buffer, pH 7.6 that contained 0.1% Triton-X-t00, 0.1% bovine albumine and 1 mg/ml bacitracin. Non-specific insulin binding was 012. The tyrosine kinase activity was measured under conditions described in the text, using the artifical substrate, poly-GluS~ 2~ insulin at the indicated concentration and the wheat germ agglutinin extract described above which contained the partially purified insulin receptor preparation. The middle panel illustrates the insulin-stimulated kinase activity expressed per insulin binding measured with 50 pmol/1125I-insulin (mean + SEM). The fight panel illustrates the insulin dose-response curve when maximum stimulation (100 nmol/l insulin) for each group was set at 100%. The symbols used and the number of subjects included are defined in the figure. Statistical significance was determined by analysis of variance. * =p < 0.05 ; ** = p < 0.01. O Non-obese control subjects, n = 7; 9 non-obese Type 2 diabetic patients, n =8; 9 obese control subjects, n =20; 9 obese Type 2 diabetic patients, n =8 determined as the amount bound in the presence of 5 [xg/ml insulin. After a 16-h incubation at 4 ~ the assay was terminated by the polyethylene glycol precipitation method as described previously [4] . Insulin degradation was less than 10% of the tracer hormone added and non-specific binding was approximately 9% of total tracer binding. The binding data were expressed as bound versus free (B/F) and normalised for the amount of protein in the assay. The latter was determined as described previously [7] .
Tyrosine kinase activity of the insulin receptor from human muscle
The tyrosine kinase activity was measured exactly under conditions previously described [5] , using the artifical substrate, poly-GluS~ 2~ In these assays, insulin at various concentrations was pre-incubated with 20 pJ of the wheat germ agglutinin extract at 24 ~ for 30 rain. The tyrosine kinase activity was then measured during a 20-min incubation at 24 ~ Termination of the assay and measurement of the amount of phosphorylated substrate were conducted as reported [5] . This assay was used to measure the kinase activity because of its sensitivity and because receptor autophosphorylation, the other method of measuring kinase activity, has uncertainties inherent in the interpretation of the results [4] . The results of the kinase experiments were expressed on the basis of insulin binding, and the basal activity (i. e., activity in the absence of insulin stimulation) was substracted from the insulin-stimulated activity.
The tyrosine kinase activity under these conditions was directly proportional to the amount of extract added and to the time period of incubation. We also examined whether any excessive destruction of ATP occurred during the incubation. ATP was separated from other nucleotides and inorganic phosphate by the method of Bochner and Ames [6] . The amount of radiolabelled ATP before and after a 20-min incubation with the wheat-germ agglutinin extract was essentially the same. This speaks against significant ATP degradation during the incubation. The tyrosine kinase activity was expressed per amount of insulin bound at tracer hormone concentration.
Statistical analysis
Data are presented as the mean+ SEM. The two tailed Student's t-test and analysis of variance were employed for statistical analysis. Table 1 illustrates the pertinent clinical information for the individuals examined in this study. The subjects in the obese diabetic or non-diabetic groups were approximately 20% overweight. Insulin resistance in the obese and diabetic groups was documented by a 2 to 3-fold elevation in fasting insulin levels and by a 40-80% decrease in intravenous glucose tolerance. The mean age was 64 years in all groups.
Insulin binding studies demonstrated a similar content of insulin receptors in the muscle extracts from the obese and diabetic groups as that found for the lean control subjects (Fig. 1, left panel) . The values for the B/F ratio per ~tg of protein were similar among the four groups at all concentrations of insulin used in the binding studies. At tracer 125I-insulin, this ratio was in the range of 0.05 ug protein (exact values are given in the legend to Figure 1) . Also, the binding affinity was similar in all groups as determined by the results from the insulin competition experiments. Fifty percent displacement of tracer insulin was produced by approximately 10 ng/ml native insulin in the receptor preparations from the four groups.
Insulin-stimulated tyrosine kinase activity for all three insulin resistant states was significantly less than the activity found in the receptors from the lean control subjects (Fig. 1, middle panel) . This alteration was present for each concentration of insulin used to stimulate the tyrosine kinase activity. With maximum insulin stimulation, the tyrosine kinase activity for the three groups of insulin-resistant subjects was approximately 40% less than the control activity. No significant differences were found, however, among the three resistant groups; all had approximately the same degree of reduction. The insulin dose-response characteristics for the activation of the receptor kinase was similar for the four groups (Fig. 1, right panel) . The half-maximum effect occurred at approximately 4 nmol/1 of insulin. The basal activity did not differ significantly between the groups. These activities (pmol phosphate incorporated/fmol of insulin binding) for the groups were: Non-obese control subjects = 1.04 + 0.21; obese control subjects--1.02 + 0.11 ; obese diabetic patients = 0.87 _+ 0.1 ; and non-obese diabetic patients = 1.08 + 0.13.
Discussion
The present study shows normal insulin binding, but inhibited insulin-induced receptor tyrosine kinase activity in human muscle in the two most common forms of insulin resistance -obesity and Type 2 diabetes. Furthermore, the decrease in enzyme activity was in the same order of magnitude in both conditions (about 40%) and the combination of the two disorders did not produce any additional changes. These observations were made in a very homogenous group of 60-year-old 439 men. It is therefore not known if women or younger subjects show other or similar changes in insulin action in obesity and Type 2 diabetes.
Insulin resistance at the target cellular level may be caused by several events, the earliest being an alteration in the receptor [1] . The insulin dose-response characteristics for the activation of the receptor kinase were similar for control and study groups. Therefore, the coupling between the insulin binding site of the receptor and the catalytic subunit remained intact in receptors that could respond to insulin by an increase in kinase activity.
The lack of an alteration in insulin binding argues against a change in the number of insulin receptors in the muscle of the insulin-resistant subjects. This interpretation must be tempered somewhat since the small amount of tissue available for the present study required detergent extraction rather than the use of isolated membranes. Thus, we cannot comment on the number of receptors available to bind inulin in the intact tissue. However, it is unlikely that a large reduction in "active" receptors exists in these subjects unless the distribution between intracellular and cell surface receptors was markedly altered.
While the present study reports on the muscle insulin receptor in obesity and diabetes, other studies have examined the insulin receptor in the liver of subjects affected with both disorders. For example, insulin binding by liver membranes of extremely obese subjects with and without diabetes is reduced [7, 8] , whereas binding is increased in normal weight Type 2 diabetic patients [9] . Thus, tlhe tissue examined and the degree of obesity evidently influences the level of the insulin receptor. However, it is evident from our results that moderate obesity in the presence or absence of Type 2 diabetes does not result in an overall loss of insulin receptors in muscle. Because of the limited amount of muscle tissue that was available it was not possible to investigate the molecular structure of the insulin receptor in the present study.
Although we cannot relate the insulin resistance in muscle to loss of insulin receptors, the alteration found in the tyrosine kinase from these patients suggests an underlying cause, i.e., an alteration in the signalling property of the receptor. Insulin stimulation of glucose transport in muscle tissue plays a major role in glucose disposal [1] . If there is a role for the tyrosine kinase activity in the stimulation of glucose transport [1] the 40% reduction in this activity observed in all three groups should alter the insulin response of affected muscle tissue and contribute to the overall in vivo insulin resistance in glucose utilisation.
The reduction in the kinase activity of muscle receptors in the absence of an insulin binding or coupling alteration suggests that some receptors have lost their phosphotransferase capability. Furthermore, insulin-stimulated tyrosine kinase activity can be modulated apparently by receptor phosphorylation and de-phosphorylation reactions [1] . These abnormalities offer an explanation for how a kinase defect can develop, although little is known of the actual molecular events that underlie such changes. For example, the ATP-dependency of insulin receptor tyrosine kinase might be altered in obesity and Type 2 diabetes mellitus. Unfortunately, it was not possible to investigate the kinetic properties of ATP-dependency for the tyrosine kinase in this study because the methods require much larger amounts of muscle tissue than was possible to obtain from each donor.
Similarly, the inciting cause of the impaired kinase activity is not known: however, the elevated insulin levels in the insulin-resistant subjects may contribute to its development. All three groups of insulin-resistant subjects had the same degree of hyperinsulinaemia and the same degree of reduction in tyrosine kinase activity. This correlation between hyperinsulinaemia and kinase activity agrees wJith prior studies of rat adipocytes [4] which demonstrated a 30-40% reduction in the tyrosine kinase activity of the insulin receptor.
As regards previous human studies, insulin receptor tyrosine kinase activity in obesity and Type 2 diabetes has recently been characterised in adipose tissue and liver. A decrease in the kinase activity of the insulin receptor has been reported in subcutaneous tissue of Type 2 diabetic patients [10] . A specific defect in the kinase activity of the hepatic insulin receptor from obese diabetic patients was found, although in contrast to the present results, no kinase alteration was evident in obese non-diabetic subjects [8] . As discussed for insulin binding, the latter difference may relate to the different tissue studied and the difference in the degree of obesity.
In summary, we conclude that the alteration in the tyrosine kinase activity is the major receptor-associated defect in muscle from obese and Type 2 diabetic patients. Because skeletal muscle is the tissue primarily responsible for insulin-stimulated disposal of glucose, the intrinsic kinase alteration rather than a loss of receptors likely accounts for the decreased glucose tolerance and insulin-resistance present in both metabolic disorders.
